Vaxart, Inc.
VXRT
$0.38
$0.00-0.16%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1,367.93% | 520.68% | 857.18% | 367.95% | 134.79% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1,367.93% | 520.68% | 857.18% | 367.95% | 134.79% |
| Cost of Revenue | 404.10% | 184.53% | 61.70% | 54.06% | 0.43% |
| Gross Profit | 65.12% | 9.69% | 41.37% | 34.83% | 21.46% |
| SG&A Expenses | -1.50% | -11.18% | -29.99% | -26.05% | -11.77% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 313.36% | 139.81% | 36.42% | 32.42% | -2.58% |
| Operating Income | 46.04% | 10.17% | 37.95% | 32.00% | 18.78% |
| Income Before Tax | 42.23% | 8.99% | 36.42% | 31.35% | 19.00% |
| Income Tax Expenses | -5.56% | -4.76% | 111.11% | 1.15% | -53.85% |
| Earnings from Continuing Operations | 42.18% | 8.99% | 36.15% | 31.02% | 19.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 42.18% | 8.99% | 36.15% | 31.02% | 19.08% |
| EBIT | 46.04% | 10.17% | 37.95% | 32.00% | 18.78% |
| EBITDA | 53.22% | 11.66% | 42.05% | 36.47% | 22.25% |
| EPS Basic | 42.49% | 26.37% | 52.70% | 56.98% | 45.94% |
| Normalized Basic EPS | 42.49% | 26.26% | 52.88% | 57.26% | 45.94% |
| EPS Diluted | 42.49% | 26.37% | 52.70% | 56.98% | 45.94% |
| Normalized Diluted EPS | 42.49% | 26.26% | 52.88% | 57.26% | 45.94% |
| Average Basic Shares Outstanding | 0.65% | 23.64% | 35.02% | 60.44% | 49.61% |
| Average Diluted Shares Outstanding | 0.65% | 23.64% | 35.02% | 60.44% | 49.61% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |